{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:26:32Z","timestamp":1790162792727,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T00:00:00Z","timestamp":1372291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/bjc.2013.334","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T22:47:24Z","timestamp":1372373244000},"page":"342-350","source":"Crossref","is-referenced-by-count":88,"title":["Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)\/Akt signaling"],"prefix":"10.1038","volume":"109","author":[{"given":"J","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,27]]},"reference":[{"issue":"5660","key":"BFbjc2013334_CR1","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1092734","volume":"303","author":"JE Chipuk","year":"2004","unstructured":"Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303 (5660): 1010\u20131014.","journal-title":"Science"},{"issue":"10","key":"BFbjc2013334_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1158\/1535-7163.MCT-12-0093","volume":"11","author":"CCR Coriat","year":"2012","unstructured":"Coriat CCR, Ch\u00e9reau C, Mir O, Alexandre J, Ropert S, Weill B, Chaussade S, Goldwasser F, Batteux F (2012) Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo. Mol Cancer Ther 11 (10): 2284\u20132293.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"BFbjc2013334_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/sj.bjc.6603291","volume":"95","author":"T Eisen","year":"2006","unstructured":"Eisen T, Ahmad T, Flaherty KT, Gore M, Kaye S, Marais R, Gibbens I, Hackett S, James M, Schuchter LM, Nathanson KL, Xia C, Simantov R, Schwartz B, Poulin-Costello M, O'Dwyer PJ, Ratain MJ (2006) Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer 95 (5): 581\u2013586.","journal-title":"Br J Cancer"},{"issue":"4","key":"BFbjc2013334_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35 (4): 495\u2013516.","journal-title":"Toxicol Pathol"},{"issue":"2","key":"BFbjc2013334_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1158\/1078-0432.CCR-07-4790","volume":"14","author":"BB Friday","year":"2008","unstructured":"Friday BB, Adjei AA (2008) Advances in targeting the Ras\/Raf\/MEK\/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin Cancer Res 14 (2): 342\u2013346.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"BFbjc2013334_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1096\/fasebj.14.7.847","volume":"14","author":"C Garcia-Ruiz","year":"2000","unstructured":"Garcia-Ruiz C, Colell A, Paris R, Fernandez-Checa JC (2000) Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. Faseb J 14 (7): 847\u2013858.","journal-title":"Faseb J"},{"issue":"42","key":"BFbjc2013334_CR7","doi-asserted-by":"publisher","first-page":"35576","DOI":"10.1074\/jbc.M112.370585","volume":"287","author":"K Gong","year":"2012","unstructured":"Gong K, Chen C, Zhan Y, Chen Y, Huang Z, Li W (2012a) Autophagy-related gene 7 (ATG7) and reactive oxygen species\/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma. J Biol Chem 287 (42): 35576\u201335588.","journal-title":"J Biol Chem"},{"issue":"3","key":"BFbjc2013334_CR8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1042\/BJ20111685","volume":"443","author":"K Gong","year":"2012","unstructured":"Gong K, Xie J, Yi H, Li W (2012b) CS055 (Chidamide\/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells. Biocheml J 443 (3): 735\u2013746.","journal-title":"Biocheml J"},{"issue":"8","key":"BFbjc2013334_CR9","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1517\/13543784.2012.689824","volume":"21","author":"WJ Gradishar","year":"2012","unstructured":"Gradishar WJ (2012) Sorafenib in locally advanced or metastatic breast cancer. Expert Opin Investig Drugs 21 (8): 1177\u20131191.","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"BFbjc2013334_CR10","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/hep.23836","volume":"52","author":"H Hikita","year":"2010","unstructured":"Hikita H, Takehara T, Shimizu S, Kodama T, Shigekawa M, Iwase K, Hosui A, Miyagi T, Tatsumi T, Ishida H, Li W, Kanto T, Hiramatsu N, Hayashi N (2010) The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib. Hepatology (Baltimore, MD 52 (4): 1310\u20131321.","journal-title":"Hepatology (Baltimore, MD"},{"issue":"10","key":"BFbjc2013334_CR11","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1002\/ijc.23752","volume":"123","author":"ZY Hu","year":"2008","unstructured":"Hu ZY, Zhu XF, Zhong ZD, Sun J, Wang J, Yang D, Zeng YX (2008) ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts. Int J Cancer 123 (10): 2418\u20132429.","journal-title":"Int J Cancer"},{"issue":"8","key":"BFbjc2013334_CR12","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.freeradbiomed.2009.01.026","volume":"46","author":"F Huang","year":"2009","unstructured":"Huang F, Nie C, Yang Y, Yue W, Ren Y, Shang Y, Wang X, Jin H, Xu C, Chen Q (2009) Selenite induces redox-dependent Bax activation and apoptosis in colorectal cancer cells. Free Radic Biol Med 46 (8): 1186\u20131196.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"BFbjc2013334_CR13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1158\/1535-7163.MCT-09-1004","volume":"9","author":"S Huang","year":"2010","unstructured":"Huang S, Sinicrope FA (2010) Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. Mol Cancer Ther 9 (3): 742\u2013750.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"BFbjc2013334_CR14","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/leu.2011.2","volume":"25","author":"S Huber","year":"2011","unstructured":"Huber S, Oelsner M, Decker T, zum Buschenfelde CM, Wagner M, Lutzny G, Kuhnt T, Schmidt B, Oostendorp RA, Peschel C, Ringshausen I (2011) Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1. Leukemia 25 (5): 838\u2013847.","journal-title":"Leukemia"},{"issue":"11","key":"BFbjc2013334_CR15","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1517\/14656566.2010.496453","volume":"11","author":"R Iyer","year":"2010","unstructured":"Iyer R, Fetterly G, Lugade A, Thanavala Y (2010) Sorafenib: a clinical and pharmacologic review. Expert Opin Pharmacother 11 (11): 1943\u20131955.","journal-title":"Expert Opin Pharmacother"},{"issue":"24","key":"BFbjc2013334_CR16","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.4161\/cbt.8.24.10824","volume":"8","author":"SI Katz","year":"2009","unstructured":"Katz SI, Zhou L, Chao G, Smith CD, Ferrara T, Wang W, Dicker DT, El-Deiry WS (2009) Sorafenib inhibits ERK1\/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma. Cancer Biol Ther 8 (24): 2406\u20132416.","journal-title":"Cancer Biol Ther"},{"issue":"9","key":"BFbjc2013334_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc1692","volume":"5","author":"Y Kondo","year":"2005","unstructured":"Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5 (9): 726\u2013734.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"BFbjc2013334_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.biopha.2011.09.011","volume":"66","author":"YC Kuo","year":"2012","unstructured":"Kuo YC, Lin WC, Chiang IT, Chang YF, Chen CW, Su SH, Chen CL, Hwang JJ (2012) Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-kappaB expression in vitro and in vivo. Biomed Pharmacother 66 (1): 12\u201320.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"BFbjc2013334_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4161\/cbt.9.6.11392","volume":"9","author":"B Leibowitz","year":"2010","unstructured":"Leibowitz B, Yu J (2010) Mitochondrial signaling in cell death via the Bcl-2 family. Cancer Biol Ther 9 (6): 417\u2013422.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"BFbjc2013334_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc2297","volume":"8","author":"AG Letai","year":"2008","unstructured":"Letai AG (2008) Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 8 (2): 121\u2013132.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"BFbjc2013334_CR21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.freeradbiomed.2006.06.010","volume":"41","author":"MH Li","year":"2006","unstructured":"Li MH, Cha YN, Surh YJ (2006) Peroxynitrite induces HO-1 expression via PI3K\/Akt-dependent activation of NF-E2-related factor 2 in PC12 cells. Free Radic Biol Med 41 (7): 1079\u20131091.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"BFbjc2013334_CR22","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/ijc.25817","volume":"129","author":"C Liu","year":"2011","unstructured":"Liu C, Gong K, Mao X, Li W (2011) Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int J Cancer 129 (6): 1519\u20131531.","journal-title":"Int J Cancer"},{"issue":"24","key":"BFbjc2013334_CR23","doi-asserted-by":"publisher","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","volume":"66","author":"L Liu","year":"2006","unstructured":"Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C (2006) Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5. Cancer Res 66 (24): 11851\u201311858.","journal-title":"Cancer Res"},{"issue":"1","key":"BFbjc2013334_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/cdd.2008.131","volume":"16","author":"MC Maiuri","year":"2009","unstructured":"Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R, Kroemer G (2009) Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 16 (1): 87\u201393.","journal-title":"Cell Death Differ"},{"issue":"1","key":"BFbjc2013334_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1200\/JCO.2009.26.7856","volume":"29","author":"D Matei","year":"2011","unstructured":"Matei D, Sill MW, Lankes HA, DeGeest K, Bristow RE, Mutch D, Yamada SD, Cohn D, Calvert V, Farley J, Petricoin EF, Birrer MJ (2011) Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial. J Clin Oncol 29 (1): 69\u201375.","journal-title":"J Clin Oncol"},{"issue":"6","key":"BFbjc2013334_CR26","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1073\/pnas.94.6.2345","volume":"94","author":"ME McCurrach","year":"1997","unstructured":"McCurrach ME, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW (1997) bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci USA 94 (6): 2345\u20132349.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"BFbjc2013334_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ijc.26073","volume":"130","author":"AE O'Connor","year":"2012","unstructured":"O'Connor AE, Mc Gee MM, Likar Y, Ponomarev V, Callanan JJ, O'Shea DF, Byrne AT, Gallagher WM (2012) Mechanism of cell death mediated by a BF2-chelated tetraaryl-azadipyrromethene photodynamic therapeutic: dissection of the apoptotic pathway in vitro and in vivo. Int J Cancer 130 (3): 705\u2013715.","journal-title":"Int J Cancer"},{"issue":"3","key":"BFbjc2013334_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1530\/ERC-11-0298","volume":"19","author":"SJ Oh","year":"2012","unstructured":"Oh SJ, Erb HH, Hobisch A, Santer FR, Culig Z (2012) Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways. Endocr Relat Cancer 19 (3): 305\u2013319.","journal-title":"Endocr Relat Cancer"},{"key":"BFbjc2013334_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1749-6632.2010.05190.x","volume":"1197","author":"HD Osiewacz","year":"2010","unstructured":"Osiewacz HD, Brust D, Hamann A, Kunstmann B, Luce K, Muller-Ohldach M, Scheckhuber CQ, Servos J, Strobel I (2010) Mitochondrial pathways governing stress resistance, life, and death in the fungal aging model Podospora anserina. Ann N Y Acad Sci 1197: 54\u201366.","journal-title":"Ann N Y Acad Sci"},{"issue":"30","key":"BFbjc2013334_CR30","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1200\/JCO.2011.37.1021","volume":"29","author":"TM Pawlik","year":"2011","unstructured":"Pawlik TM, Reyes DK, Cosgrove D, Kamel IR, Bhagat N, Geschwind JF (2011) Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. J Clin Oncol 29 (30): 3960\u20133967.","journal-title":"J Clin Oncol"},{"issue":"17","key":"BFbjc2013334_CR31","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1158\/0008-5472.CAN-11-1014","volume":"71","author":"JR Pritchard","year":"2011","unstructured":"Pritchard JR, Gilbert LA, Meacham CE, Ricks JL, Jiang H, Lauffenburger DA, Hemann MT (2011) Bcl-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic response. Cancer Res 71 (17): 5850\u20135858.","journal-title":"Cancer Res"},{"issue":"4","key":"BFbjc2013334_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1634\/theoncologist.11-4-342","volume":"11","author":"MS Ricci","year":"2006","unstructured":"Ricci MS, Zong WX (2006) Chemotherapeutic approaches for targeting cell death pathways. Oncologist 11 (4): 342\u2013357.","journal-title":"Oncologist"},{"issue":"19","key":"BFbjc2013334_CR33","doi-asserted-by":"publisher","first-page":"9490","DOI":"10.1158\/0008-5472.CAN-07-0598","volume":"67","author":"RR Rosato","year":"2007","unstructured":"Rosato RR, Almenara JA, Coe S, Grant S (2007) The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation. Cancer Res 67 (19): 9490\u20139500.","journal-title":"Cancer Res"},{"issue":"1","key":"BFbjc2013334_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1042\/BJ20080972","volume":"417","author":"DP Santana","year":"2009","unstructured":"Santana DP, Faria PA, Paredes-Gamero EJ, Caires AC, Nantes IL, Rodrigues T (2009) Palladacycles catalyse the oxidation of critical thiols of the mitochondrial membrane proteins and lead to mitochondrial permeabilization and cytochrome c release associated with apoptosis. Biochem J 417 (1): 247\u2013256.","journal-title":"Biochem J"},{"issue":"1","key":"BFbjc2013334_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1517\/14728222.2011.645805","volume":"16","author":"L Santarpia","year":"2012","unstructured":"Santarpia L, Lippman SM, El-Naggar AK (2012) Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets 16 (1): 103\u2013119.","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"BFbjc2013334_CR36","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1476-5381.2009.00605.x","volume":"159","author":"DF Shen","year":"2010","unstructured":"Shen DF, Tang QZ, Yan L, Zhang Y, Zhu LH, Wang L, Liu C, Bian ZY, Li H (2010) Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1\/2 signalling. Br J Pharmacol 159 (4): 970\u2013981.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"BFbjc2013334_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1615\/CritRevOncog.v17.i1.60","volume":"17","author":"K Sheppard","year":"2012","unstructured":"Sheppard K, Kinross KM, Solomon B, Pearson RB, Phillips WA (2012) Targeting PI3 kinase\/AKT\/mTOR signaling in cancer. Crit Rev Oncog 17 (1): 69\u201395.","journal-title":"Crit Rev Oncog"},{"issue":"6","key":"BFbjc2013334_CR38","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.freeradbiomed.2011.06.008","volume":"51","author":"S Shin-Kang","year":"2011","unstructured":"Shin-Kang S, Ramsauer VP, Lightner J, Chakraborty K, Stone W, Campbell S, Reddy SA, Krishnan K (2011) Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway. Free Radic Biol Med 51 (6): 1164\u20131174.","journal-title":"Free Radic Biol Med"},{"issue":"5698","key":"BFbjc2013334_CR39","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.1099993","volume":"306","author":"T Shintani","year":"2004","unstructured":"Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306 (5698): 990\u2013995.","journal-title":"Science"},{"issue":"9","key":"BFbjc2013334_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrm2952","volume":"11","author":"SW Tait","year":"2010","unstructured":"Tait SW, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11 (9): 621\u2013632.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"BFbjc2013334_CR41","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/ijc.26252","volume":"130","author":"M Vandamme","year":"2012","unstructured":"Vandamme M, Robert E, Lerondel S, Sarron V, Ries D, Dozias S, Sobilo J, Gosset D, Kieda C, Legrain B, Pouvesle JM, Pape AL (2012) ROS implication in a new antitumor strategy based on non-thermal plasma. Int J Cancer 130 (9): 2185\u20132194.","journal-title":"Int J Cancer"},{"issue":"1","key":"BFbjc2013334_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/cdd.2011.158","volume":"19","author":"M Vogler","year":"2012","unstructured":"Vogler M (2012) BCL2A1: the underdog in the BCL2 family. Cell Death Differ 19 (1): 67\u201374.","journal-title":"Cell Death Differ"},{"issue":"2","key":"BFbjc2013334_CR43","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/mol.109.056523","volume":"76","author":"T Walker","year":"2009","unstructured":"Walker T, Mitchell C, Park MA, Yacoub A, Graf M, Rahmani M, Houghton PJ, Voelkel-Johnson C, Grant S, Dent P (2009) Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms. Mol Pharmacol 76 (2): 342\u2013355.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"BFbjc2013334_CR44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.bbrc.2012.05.056","volume":"422","author":"L Wang","year":"2012","unstructured":"Wang L, Jia D, Duan F, Sun Z, Liu X, Zhou L, Sun L, Ren S, Ruan Y, Gu J (2012) Combined anti-tumor effects of IFN-alpha and sorafenib on hepatocellular carcinoma in vitro and in vivo. Biochem Biophys Res Commun 422 (4): 687\u2013692.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"BFbjc2013334_CR45","first-page":"835","volume":"5","author":"S Wilhelm","year":"2006","unstructured":"Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B, Simantov R, Kelley S (2006) Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev 5 (10): 835\u2013844.","journal-title":"Nat Rev"},{"issue":"2","key":"BFbjc2013334_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.canlet.2009.06.009","volume":"287","author":"JM Wu","year":"2010","unstructured":"Wu JM, Chen Y, Chen JC, Lin TY, Tseng SH (2010) Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice. Cancer Lett 287 (2): 187\u2013195.","journal-title":"Cancer Lett"},{"issue":"9","key":"BFbjc2013334_CR47","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1517\/13543784.2012.699039","volume":"21","author":"J Zhang","year":"2012","unstructured":"Zhang J, Gold KA, Kim E (2012) Sorafenib in non-small cell lung cancer. Expert Opin Investig Drugs 21 (9): 1417\u20131426.","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"BFbjc2013334_CR48","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/sj.leu.2405098","volume":"22","author":"W Zhang","year":"2008","unstructured":"Zhang W, Konopleva M, Ruvolo VR, McQueen T, Evans RL, Bornmann WG, McCubrey J, Cortes J, Andreeff M (2008a) Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway. Leukemia 22 (4): 808\u2013818.","journal-title":"Leukemia"},{"issue":"3","key":"BFbjc2013334_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/jnci\/djm328","volume":"100","author":"W Zhang","year":"2008","unstructured":"Zhang W, Konopleva M, Shi YX, McQueen T, Harris D, Ling X, Estrov Z, Quintas-Cardama A, Small D, Cortes J, Andreeff M (2008b) Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia. J Natl Cancer Inst 100 (3): 184\u2013198.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"BFbjc2013334_CR50","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","volume":"1813","author":"X Zhang","year":"2011","unstructured":"Zhang X, Tang N, Hadden TJ, Rishi AK (2011) Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 1813 (11): 1978\u20131986.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"BFbjc2013334_CR51","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/neuonc\/nor066","volume":"13","author":"DS Ziegler","year":"2011","unstructured":"Ziegler DS, Keating J, Kesari S, Fast EM, Zawel L, Ramakrishna N, Barnes J, Kieran MW, Veldhuijzen van Zanten SE, Kung AL (2011) A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo. Neuro-oncology 13 (8): 820\u2013829.","journal-title":"Neuro-oncology"},{"issue":"5\u20136","key":"BFbjc2013334_CR52","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbabio.2006.04.029","volume":"1757","author":"DB Zorov","year":"2006","unstructured":"Zorov DB, Juhaszova M, Sollott SJ (2006) Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta 1757 (5\u20136): 509\u2013517.","journal-title":"Biochim Biophys Acta"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2013334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013334","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:15:35Z","timestamp":1684415735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2013334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,27]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFbjc2013334"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2013.334","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,27]]}}}